Part 1. Blood components (erythrocytes)

This tender concerns the procurement of blood components, specifically erythrocytes, for the Public Institution Regional Mažeikiai Hospital (VšĮ Regioninei Mažeikių ligoninei). The contract aims to ensure a stable and reliable supply of essential blood products for the hospital's medical services. Erythrocytes, also known as red blood cells, are critical for oxygen transport throughout the body and are used in various medical treatments, including surgery, trauma care, and management of chronic conditions like anemia. The procurement is vital for maintaining the hospital's capacity to provide high-quality patient care and respond effectively to medical emergencies. Interested suppliers are expected to meet stringent quality standards and regulatory requirements for blood component provision. The contract duration and specific quantities will be detailed in the tender documentation. This procurement falls under the healthcare sector, focusing on essential medical supplies. The Mažeikiai Regional Hospital relies on such provisions to sustain its operations and serve the health needs of the local community. Further details regarding technical specifications, delivery schedules, and evaluation criteria will be made available to prospective bidders through the official tender portal.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Lithuania, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.